 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction |
| Nam Hoon Kim, Sin Gon Kim |
|
Diabetes Metab J. 2020;44(2):213-221. Published online April 23, 2020 DOI: https://doi.org/10.4093/dmj.2020.0001 |
|
Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction Diabetes & Metabolism Journal. 2020;44(2):213  Fibrates and coronary risk reduction Atherosclerosis. 2005;182(2):199-207 Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis Atherosclerosis. 2011;217(2):492-498 EXERCISE REVISITED: A CARDIOVASCULAR RISK REDUCTION STRATEGY Canadian Journal of Cardiology. 2014;30(10):S371-S372 Treatment of massive hypertriglyceridemias resistant to pufa and fibrates: A possible role for the coenzyma Q10? Nutrition, Metabolism and Cardiovascular Diseases. 2003;13(5):329 Oxidative Stress and the Role of Antioxidants in Cardiovascular Risk Reduction Progress in Cardiovascular Nursing. 2007;16(1):30-32 Clinical potential of vorapaxar in cardiovascular risk reduction in patients with atherosclerosis Therapeutics and Clinical Risk Management. 2015;1133 Fibrates: Modes of Action Multiple Risk Factors in Cardiovascular Disease. 1995;295-306 Role of green tea in reduction of cardiovascular risk factors Nutrition and Dietary Supplements. 2010;85 Fibrates: Risk Benefits and Role in Treating Dyslipidemias Contemporary Endocrinology. 2015;423-438 |
